Navigation Links
Precancerous Esophagus Disease Eliminated in 98.4% of Patients Treated With HALO Ablation System
Date:7/20/2008

us, such as Barrett's esophagus. The HALO90 ablation system, by comparison, is an electrode system that is mounted on the end of an endoscope, allowing the physician to treat focal areas of diseased tissue in the esophagus, stomach, colon, rectum and anus. Both HALO systems provide uniform and controlled therapy at a consistent depth, which enables removal of diseased tissue and regrowth of normal cells. Both systems are cleared by the U.S. Food and Drug Administration, have CE mark certification in Europe, and are commercially available in the U.S. and other selected countries. Based in Sunnyvale, Calif., BARRX Medical, Inc. is a privately held company. Additional information about BARRX Medical, Inc. and the HALO ablation systems is available at http://www.barrx.com.


'/>"/>
SOURCE BARRX Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Topical Cream Treats Precancerous Lesions of Vulva
2. Precancerous Breast Lesions Cause Unnecessary Worry
3. Precancerous Lesions Raise Cervical Cancer Risk
4. Radiofrequency ablation is effective treatment for dysplasia in Barretts esophagus
5. Removal of superficial tumors in esophagus by endoscopy can avoid extirpation of this part
6. New techniques improve imaging quality, not diagnosis of Barretts esophagus
7. Calcium may be the key to understanding Alzheimers disease
8. Insight into mechanisms of diabetes-induced microvascular disease reveals new therapies
9. Kidney Community Thanks Congress for Passing Landmark End Stage Renal Disease (ESRD) Reform
10. Diabetes could be a hidden condition for heart disease patients
11. Ingenuity Systems and CHDI Announce Multi-Year Deal for Disease-Specific Knowledge Platform

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ogist Closer to Understanding Brain Wiring and Dis...wire/ -- Dr. Jeremy Schmahmann, Professor of Neuro...the Massachusetts General Hospital in Boston, on T...esearch on the new field of study called "Connecti..., Dr. Schmahmann is an award-winning leader in t...
(Date:11/20/2009)...Nov. 20 The United Stat... to make essential changes its health reform bill ...funding and conscience protection on abortion, pro...ude strong provisions for adequate affordability. ...ll an "enormous disappointment" that creates new a...
(Date:11/20/2009)... Nov. 20 Rates of infect...ed in late October, but the pandemic flu virus con...age groups, including the elderly, according to a ...: DGX ), the world,s leading provider of diagnos...ts most recent Quest Diagnostics Health Trends(TM)...
(Date:11/20/2009)...ael, November 20 Cardio ...ww.CVSLMEDICAL.COM , a leading,developer of advanc...ced that,the company,s Board of Directors has deci...ada and the Far East for its proprietary next-gene...gioplasty (PCTA) procedures. , Cardio Vas...
(Date:11/20/2009)...v. 20 SIRIUS XM Radio ...dcast Doctor Radio Reports: What Every Women Ne... hosted by veteran journalist Perri Peltz. ,, ...19/NYTU044LOGO ) ,, Doctor Radio Reports: Wh...l air November 21 live at 10:00 am ET on Doctor ...
Breaking Medicine News(10 mins):Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5
...al breakthroughs in recent decades have allowed he...nts to live longer. But as their hearts decline in...will experience disability and the need for nursin...ty among people with CHF, as well as the implicati...
...d sense of smell is an early indicator of Parkinso...st can help determine if people with no symptoms e...d be like diagnosing coronary artery disease befor...kinsons Associated Risk Syndrome Study. With Parki...
...nal Health, Inc.,(NYSE: CAH ), a global provider ...nd productivity of health care, plans to release s...ay, Jan. 29, prior to the opening of,trading on th...orresponding slide,presentation, go to the Investo...
...way Clinical Laboratories, (http://www.parkwayclin...ed,clinical reference laboratory located in Bensal...g Mats Sanden, M.D., as medical director, Masood,H...e New Year with a resolve to rapidly grow our vari...
...MedPredict Market Research, a,global provider of p...research, has published "Thought Leader Insight & ...trategic insight for pharma and biotech,companies ...nd cardiovascular disease, however, the,medical ju...
...le in Spanish . , A group of scientists led by ...istry and Molecular Biology at Universitat Autnoma..., an enzyme that is detected in large quantities o...ous. Thus this molecule would serve as a good mark...
Other Medicine News:Health News:Congestive heart failure leads to greater disability, nursing home admissions 2Health News:Risk factors for Parkinson's disease under study 2Health News:Cardinal Health to Announce Second-Quarter Results on January 29 2Health News:Parkway Clinical Laboratories Expands Management Team to Support a National Growth Strategy Centered on Oral Fluid Drug Screening 2Health News:Pipeline for New Obesity Therapies is Focus of New Report 2Health News:UAB research could improve the prognosis and treatment of lung cancer 2
(Date:11/20/2009)...ICK, Mass. and LONDON, Nov. 20 /PRNewswire-FirstCa...) today announced that it has received 510(k) clea...FDA) and CE Mark approval to market its WallFlex&#...ent of malignant esophageal strictures (obstructio...r non-resectable esophageal cancer. ,, (Photo:...
(Date:11/20/2009)...YMOUTH MEETING, Pa., Nov. 20 /PRNewswire-USNewswir...icle that questions why currently available medica...re being ignored, ECRI Institute, an independent n...e evidence on Finasteride for Prevention of Prost...r 13, 2009, New York Times article, " Drugs to D...
(Date:11/20/2009)...NCETON, N.J., Nov. 20 So...x or the Company), formerly known as DOR BioPharma...ced today that it has formed a consortium to devel...d other rapidly acting vaccines. Soligenix receive... of Allergy and Infectious Diseases (NIAID), a div...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 1Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 2Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 3Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 4T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 1T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 2T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 3Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 1Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 2Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 3
...uly 16 MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP )...2 study evaluating the safety, tolerability and,ph... published in the July,issue of Current Medical Re...ing MAP0004, an orally inhaled and self-administer..., The study results, which were first announced l...
...ble Phase 1 RX-3341 Results -, NEW HAVEN, Conn., ...he "Company"), a development-stage company focused...tics for the treatment of,antibiotic-resistant inf...,2 clinical trial for an intravenous form of antib...ated skin and skin structure infections (cSSSIs).,...
Other Medicine Technology:MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 2MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 4Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 2Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 3
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: